Opin vísindi

Fletta eftir höfundi "Souillard-Mandar, William"

Fletta eftir höfundi "Souillard-Mandar, William"

Röðun: Raða: Niðurstöður:

  • Curcic, Jelena; Vallejo, Vanessa; Sorinas, Jennifer; Sverdlov, Oleksandr; Praestgaard, Jens; Piksa, Mateusz; Deurinck, Mark; Erdemli, Gul; Bügler, Maximilian; Tarnanas, Ioannis; Taptiklis, Nick; Cormack, Francesca; Anker, Rebekka; Massé, Fabien; Souillard-Mandar, William; Intrator, Nathan; Molcho, Lior; Madero, Erica; Bott, Nicholas; Chambers, Mieko; Tamory, Josef; Shulz, Matias; Fernandez, Gerardo; Simpson, William; Robin, Jessica; Snædal, Jón G; Cha, Jang-Ho; Hannesdottir, Kristin (2022-08-10)
    BACKGROUND: More sensitive and less burdensome efficacy end points are urgently needed to improve the effectiveness of clinical drug development for Alzheimer disease (AD). Although conventional end points lack sensitivity, digital technologies hold ...